InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,224.30
(
0.06%
)
US TECH 100
17,760.20
(
0.21%
)
Dow Jones
39,426.30
(
-0.01%
)
Brent Oil
82.06
(
-1.38%
)
Bitcoin
61,819.89
(
-1.72%
)
Post# of 45815
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BCNstocks

Send PM Follow Ignore
Followers 496
Posts 62722
Boards Moderated 0
Alias Born 08/28/2010

BCNstocks

Re: None

Friday, 10/11/2019 10:36:39 AM

Friday, October 11, 2019 10:36:39 AM

Post# of 45815
$GTBP ~ GT Biopharma recently announced the sale of their fixed dose combination Tablet (GTB-004) for Myasthenia Gravis (Chronic Autoimmune Disease) to DAS Therapeutics >>

https://www.barchart.com/story/stocks/quotes/GTBP/news/3694370/gt-biopharma-announces-the-sale-of-its-fixed-dose-combination-tablet-gtb-004-for-myasthenia-gravis-chronic-autoimmune-disease-to-das-therapeutics

Under the terms of the Asset Purchase Agreement, DAS Therapeutics acquires all rights, title, clinical data, composition-of-matter and use patents related to GTB-004. GT Biopharma will receive a $200,000 up-front payment, annual royalties of 1.5% of Net Yearly Sales, and a $6 million payment based on achievement of commercial milestone.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up